2013
DOI: 10.1093/brain/awt092
|View full text |Cite
|
Sign up to set email alerts
|

Abnormal recruitment of extracellular matrix proteins by excess Notch3ECD: a new pathomechanism in CADASIL

Abstract: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, or CADASIL, one of the most common inherited small vessel diseases of the brain, is characterized by a progressive loss of vascular smooth muscle cells and extracellular matrix accumulation. The disease is caused by highly stereotyped mutations within the extracellular domain of the NOTCH3 receptor (Notch3(ECD)) that result in an odd number of cysteine residues. While CADASIL-associated NOTCH3 mutations differentially a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
207
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 174 publications
(224 citation statements)
references
References 40 publications
16
207
1
Order By: Relevance
“…Thus, it would appear that several mechanisms contribute to vascular damage in CADASIL. The NOTCH3ECD cascade hypothesis (Monet-Leprêtre et al, 2013) suggests that NOTCH3-induced GOM scavenges extracellular matrix proteins, contributing to toxic effects. This hypothesis is also supported by animal models in which the strongest CADASIL phenotype is seen in mice expressing the highest levels of mutated Notch3 (Rutten et al, 2015).…”
Section: Notch3 In Development: a Cornucopia Of Congenital Disordersmentioning
confidence: 99%
“…Thus, it would appear that several mechanisms contribute to vascular damage in CADASIL. The NOTCH3ECD cascade hypothesis (Monet-Leprêtre et al, 2013) suggests that NOTCH3-induced GOM scavenges extracellular matrix proteins, contributing to toxic effects. This hypothesis is also supported by animal models in which the strongest CADASIL phenotype is seen in mice expressing the highest levels of mutated Notch3 (Rutten et al, 2015).…”
Section: Notch3 In Development: a Cornucopia Of Congenital Disordersmentioning
confidence: 99%
“…135 Based on mouse models of CADASIL, targeting the synthesis of NOTCH3 or the clearance of NOTCH3ECD deposits, might represent a first therapeutic option. 136 Upregulation of Kv1 channels in cerebral arteries has been shown to be the molecular mechanism underlying the diminished myogenic responses in mutant mice. 137 Treatment of hypertension and other vascular risk factors, anti-aggregants, and anti-inflammatory drugs are other possible avenues.…”
Section: Treatments In Animal Modelsmentioning
confidence: 99%
“…In view of the considerations of Monet‐Leprêtre et al. (2013) about the accumulation of tissue inhibitor of metalloproteinase 3 (TIMP3) on the perimeter of GOM deposits, it is conceivable that a more densely packed extracellular matrix around the GOM could be the result of reduced metalloproteinase 3 activity. The halo could represent the result of this event.…”
Section: Discussionmentioning
confidence: 99%